Overview
The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.
Eligibility
Inclusion Criteria:
- Documented diagnosis of PH1, per physician's determination
Exclusion Criteria:
- Currently enrolled in a clinical trial for any investigational agent